Cholinesterase inhibitors associated with lower rate of mortality in dementia patients with heart failure: a nationwide propensity weighting study.
Ming-Jer HsiehCheng-Hung LeeDong-Yi ChenChia-Ling WuYu-Tung HuangShang-Hung ChangPublished in: Clinical autonomic research : official journal of the Clinical Autonomic Research Society (2023)
The results of this retrospective cohort study suggest that ChEIs may be beneficial in reducing all-cause and cardiovascular mortality in patients with dementia with HF. Further research is needed to validate these findings and explore the potential benefits of ChEIs in all patients with HF, including those without dementia.